Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Amino Acid Metabolism, Inborn Errors | 45 | 2024 | 282 | 13.390 |
Why?
|
Succinate-Semialdehyde Dehydrogenase | 51 | 2024 | 96 | 12.790 |
Why?
|
Epilepsy | 70 | 2024 | 3267 | 7.610 |
Why?
|
Developmental Disabilities | 37 | 2024 | 1504 | 5.790 |
Why?
|
gamma-Aminobutyric Acid | 29 | 2024 | 1132 | 3.750 |
Why?
|
Spasms, Infantile | 13 | 2023 | 296 | 3.470 |
Why?
|
Metabolism, Inborn Errors | 8 | 2021 | 285 | 2.260 |
Why?
|
Electroencephalography | 55 | 2024 | 6189 | 2.190 |
Why?
|
Brain Diseases, Metabolic, Inborn | 8 | 2011 | 45 | 2.180 |
Why?
|
Seizures | 39 | 2024 | 2917 | 2.040 |
Why?
|
Neurology | 8 | 2024 | 779 | 1.940 |
Why?
|
Pyridoxine | 8 | 2022 | 108 | 1.940 |
Why?
|
Anticonvulsants | 17 | 2024 | 1879 | 1.550 |
Why?
|
4-Aminobutyrate Transaminase | 3 | 2019 | 13 | 1.480 |
Why?
|
Epilepsies, Partial | 8 | 2023 | 430 | 1.440 |
Why?
|
Hydroxybutyrates | 8 | 2018 | 79 | 1.360 |
Why?
|
Neurotransmitter Agents | 7 | 2018 | 663 | 1.330 |
Why?
|
Child | 128 | 2024 | 79806 | 1.290 |
Why?
|
Bioethics | 2 | 2020 | 117 | 1.270 |
Why?
|
Metabolic Diseases | 3 | 2024 | 686 | 1.270 |
Why?
|
Sodium Oxybate | 4 | 2023 | 33 | 1.270 |
Why?
|
Vigabatrin | 5 | 2021 | 88 | 1.250 |
Why?
|
Hemiplegia | 2 | 2022 | 136 | 1.230 |
Why?
|
Epilepsies, Myoclonic | 4 | 2023 | 85 | 1.060 |
Why?
|
Aldehyde Oxidoreductases | 7 | 2004 | 87 | 1.050 |
Why?
|
Magnetoencephalography | 12 | 2024 | 634 | 1.030 |
Why?
|
Pyridoxaminephosphate Oxidase | 3 | 2017 | 8 | 0.910 |
Why?
|
Aromatic-L-Amino-Acid Decarboxylases | 4 | 2023 | 27 | 0.850 |
Why?
|
Child, Preschool | 61 | 2024 | 42063 | 0.840 |
Why?
|
Societies, Medical | 6 | 2024 | 3905 | 0.830 |
Why?
|
Pediatrics | 7 | 2024 | 3586 | 0.830 |
Why?
|
Hemispherectomy | 4 | 2023 | 40 | 0.790 |
Why?
|
Aldehyde Dehydrogenase | 4 | 2022 | 147 | 0.790 |
Why?
|
Humans | 222 | 2024 | 760621 | 0.760 |
Why?
|
Magnetic Resonance Imaging | 46 | 2024 | 36290 | 0.760 |
Why?
|
Adolescent | 74 | 2024 | 87810 | 0.690 |
Why?
|
Brain | 33 | 2024 | 26951 | 0.680 |
Why?
|
Sodium-Potassium-Exchanging ATPase | 1 | 2022 | 477 | 0.660 |
Why?
|
Physician Executives | 1 | 2020 | 133 | 0.660 |
Why?
|
Congresses as Topic | 2 | 2021 | 805 | 0.640 |
Why?
|
Infant | 46 | 2024 | 36060 | 0.640 |
Why?
|
Lysine | 2 | 2022 | 1001 | 0.640 |
Why?
|
Spastic Paraplegia, Hereditary | 1 | 2021 | 168 | 0.630 |
Why?
|
Receptors, GABA-A | 2 | 2016 | 621 | 0.630 |
Why?
|
Piracetam | 3 | 2013 | 88 | 0.630 |
Why?
|
Brain Waves | 5 | 2024 | 401 | 0.630 |
Why?
|
Speech | 2 | 2021 | 550 | 0.610 |
Why?
|
Intelligence | 2 | 2023 | 921 | 0.610 |
Why?
|
Leadership | 3 | 2024 | 1371 | 0.610 |
Why?
|
Induced Pluripotent Stem Cells | 3 | 2024 | 1846 | 0.610 |
Why?
|
Genetic Association Studies | 4 | 2021 | 2717 | 0.600 |
Why?
|
Brain Diseases, Metabolic | 2 | 2017 | 44 | 0.600 |
Why?
|
Cerebellum | 3 | 2020 | 1496 | 0.570 |
Why?
|
Pandemics | 4 | 2020 | 8624 | 0.560 |
Why?
|
Advisory Committees | 1 | 2021 | 788 | 0.560 |
Why?
|
Retinal Degeneration | 1 | 2021 | 412 | 0.560 |
Why?
|
Thyroid Hormones | 2 | 2018 | 403 | 0.560 |
Why?
|
Glutamate-tRNA Ligase | 1 | 2016 | 2 | 0.540 |
Why?
|
Mutation, Missense | 6 | 2024 | 2566 | 0.540 |
Why?
|
Auditory Perception | 1 | 2021 | 580 | 0.530 |
Why?
|
Phenotype | 17 | 2023 | 16546 | 0.510 |
Why?
|
Transcranial Magnetic Stimulation | 4 | 2022 | 1469 | 0.500 |
Why?
|
Periodicity | 1 | 2016 | 348 | 0.500 |
Why?
|
Brain Edema | 2 | 2018 | 603 | 0.500 |
Why?
|
De Lange Syndrome | 1 | 2015 | 21 | 0.490 |
Why?
|
Flumazenil | 2 | 2017 | 84 | 0.480 |
Why?
|
Motor Cortex | 4 | 2022 | 995 | 0.480 |
Why?
|
Interprofessional Relations | 1 | 2020 | 989 | 0.460 |
Why?
|
Male | 103 | 2024 | 359744 | 0.460 |
Why?
|
Hypoxia-Ischemia, Brain | 2 | 2017 | 352 | 0.460 |
Why?
|
Chorea | 1 | 2014 | 79 | 0.460 |
Why?
|
Dyslexia | 1 | 2015 | 208 | 0.450 |
Why?
|
Taurine | 1 | 2014 | 93 | 0.450 |
Why?
|
Female | 107 | 2024 | 391270 | 0.440 |
Why?
|
Epilepsy, Post-Traumatic | 1 | 2013 | 40 | 0.430 |
Why?
|
Dopamine beta-Hydroxylase | 1 | 2013 | 74 | 0.430 |
Why?
|
GTP Cyclohydrolase | 1 | 2013 | 47 | 0.420 |
Why?
|
Leukoencephalopathies | 1 | 2016 | 249 | 0.420 |
Why?
|
Monoamine Oxidase | 1 | 2013 | 178 | 0.410 |
Why?
|
Suicide | 1 | 2023 | 1599 | 0.400 |
Why?
|
Nervous System Diseases | 3 | 2009 | 1647 | 0.400 |
Why?
|
Psychomotor Disorders | 1 | 2013 | 149 | 0.400 |
Why?
|
Brain Mapping | 14 | 2023 | 6568 | 0.400 |
Why?
|
Practice Guidelines as Topic | 5 | 2024 | 7475 | 0.390 |
Why?
|
Phenylketonurias | 1 | 2013 | 123 | 0.390 |
Why?
|
Critical Illness | 3 | 2021 | 2709 | 0.380 |
Why?
|
Family | 3 | 2021 | 3189 | 0.380 |
Why?
|
Health Surveys | 1 | 2021 | 4063 | 0.380 |
Why?
|
Music | 2 | 2015 | 245 | 0.370 |
Why?
|
Sequence Deletion | 1 | 2015 | 1493 | 0.370 |
Why?
|
Nervous System Physiological Phenomena | 1 | 2011 | 114 | 0.360 |
Why?
|
Monitoring, Physiologic | 4 | 2021 | 1784 | 0.360 |
Why?
|
Vitamins | 3 | 2024 | 1634 | 0.360 |
Why?
|
Genetics | 1 | 2011 | 114 | 0.360 |
Why?
|
Young Adult | 33 | 2024 | 58741 | 0.360 |
Why?
|
Brain Injuries | 5 | 2020 | 2044 | 0.350 |
Why?
|
Infant, Newborn | 20 | 2023 | 26181 | 0.350 |
Why?
|
Norepinephrine | 1 | 2013 | 900 | 0.350 |
Why?
|
Autonomic Nervous System Diseases | 1 | 2013 | 269 | 0.350 |
Why?
|
Attention Deficit Disorder with Hyperactivity | 7 | 2005 | 3701 | 0.340 |
Why?
|
GABA-A Receptor Antagonists | 1 | 2009 | 60 | 0.340 |
Why?
|
Knowledge | 1 | 2011 | 176 | 0.340 |
Why?
|
Phytotherapy | 1 | 2011 | 295 | 0.330 |
Why?
|
Dystonia | 1 | 2013 | 364 | 0.330 |
Why?
|
Sodium Channels | 1 | 2011 | 344 | 0.330 |
Why?
|
Stereotypic Movement Disorder | 1 | 2009 | 30 | 0.330 |
Why?
|
Brain Diseases | 3 | 2016 | 1540 | 0.320 |
Why?
|
Stereotaxic Techniques | 4 | 2024 | 549 | 0.320 |
Why?
|
Patient Care Team | 1 | 2020 | 2511 | 0.320 |
Why?
|
Lesch-Nyhan Syndrome | 1 | 2008 | 16 | 0.320 |
Why?
|
Craniocerebral Trauma | 1 | 2013 | 491 | 0.320 |
Why?
|
Dystonic Disorders | 1 | 2013 | 340 | 0.310 |
Why?
|
Famous Persons | 1 | 2009 | 109 | 0.310 |
Why?
|
Mental Disorders | 4 | 2021 | 6796 | 0.290 |
Why?
|
Food, Formulated | 1 | 2008 | 102 | 0.290 |
Why?
|
Functional Laterality | 7 | 2023 | 2253 | 0.280 |
Why?
|
Spinal Puncture | 2 | 2006 | 281 | 0.280 |
Why?
|
Status Epilepticus | 4 | 2018 | 456 | 0.280 |
Why?
|
Central Nervous System | 1 | 2014 | 1334 | 0.270 |
Why?
|
Uveitis | 1 | 2010 | 393 | 0.270 |
Why?
|
Health Personnel | 1 | 2020 | 3310 | 0.270 |
Why?
|
Disorders of Excessive Somnolence | 1 | 2009 | 277 | 0.260 |
Why?
|
Pyridoxal Phosphate | 5 | 2017 | 124 | 0.260 |
Why?
|
DNA Mutational Analysis | 2 | 2014 | 4107 | 0.260 |
Why?
|
Fatal Outcome | 3 | 2018 | 1832 | 0.260 |
Why?
|
Electrodes, Implanted | 3 | 2024 | 833 | 0.260 |
Why?
|
Patient Education as Topic | 2 | 2014 | 2315 | 0.260 |
Why?
|
Autistic Disorder | 3 | 2004 | 1216 | 0.260 |
Why?
|
Rare Diseases | 2 | 2021 | 619 | 0.260 |
Why?
|
Coronavirus Infections | 2 | 2020 | 3085 | 0.260 |
Why?
|
Pneumonia, Viral | 2 | 2020 | 3205 | 0.250 |
Why?
|
Vagus Nerve | 1 | 2008 | 458 | 0.250 |
Why?
|
Databases, Factual | 3 | 2021 | 8035 | 0.250 |
Why?
|
Diet, Carbohydrate-Restricted | 1 | 2008 | 261 | 0.250 |
Why?
|
Language Development Disorders | 3 | 2020 | 192 | 0.240 |
Why?
|
Metabolic Networks and Pathways | 2 | 2020 | 789 | 0.240 |
Why?
|
Sarcoidosis | 1 | 2010 | 520 | 0.240 |
Why?
|
Carnosine | 1 | 2004 | 6 | 0.240 |
Why?
|
Healthcare Disparities | 1 | 2020 | 3388 | 0.240 |
Why?
|
Nerve Fibers, Myelinated | 1 | 2010 | 952 | 0.230 |
Why?
|
Treatment Outcome | 22 | 2024 | 65017 | 0.230 |
Why?
|
Muscle Hypotonia | 2 | 2020 | 160 | 0.230 |
Why?
|
Educational Measurement | 1 | 2011 | 1248 | 0.230 |
Why?
|
Landau-Kleffner Syndrome | 1 | 2003 | 10 | 0.230 |
Why?
|
Polysomnography | 2 | 2009 | 1825 | 0.220 |
Why?
|
Median Nerve | 1 | 2024 | 132 | 0.220 |
Why?
|
Age of Onset | 8 | 2021 | 3301 | 0.220 |
Why?
|
Ataxia | 2 | 2020 | 305 | 0.220 |
Why?
|
Retrospective Studies | 37 | 2024 | 80372 | 0.220 |
Why?
|
Needles | 1 | 2006 | 451 | 0.210 |
Why?
|
Movement Disorders | 2 | 2024 | 459 | 0.210 |
Why?
|
Aquaporin 4 | 1 | 2023 | 159 | 0.210 |
Why?
|
Sleep Deprivation | 1 | 2009 | 840 | 0.210 |
Why?
|
Cerebellar Diseases | 2 | 2018 | 219 | 0.210 |
Why?
|
Disease Models, Animal | 11 | 2024 | 18137 | 0.210 |
Why?
|
Language | 7 | 2023 | 1533 | 0.200 |
Why?
|
Biotin | 1 | 2023 | 253 | 0.200 |
Why?
|
Evoked Potentials, Somatosensory | 1 | 2024 | 246 | 0.200 |
Why?
|
Telemedicine | 3 | 2020 | 3018 | 0.200 |
Why?
|
Adult | 41 | 2024 | 219994 | 0.200 |
Why?
|
Uric Acid | 1 | 2008 | 806 | 0.200 |
Why?
|
Laryngostenosis | 1 | 2023 | 167 | 0.200 |
Why?
|
Carboxy-Lyases | 1 | 2021 | 85 | 0.190 |
Why?
|
Complementary Therapies | 1 | 2005 | 486 | 0.190 |
Why?
|
Congenital Disorders of Glycosylation | 1 | 2001 | 48 | 0.190 |
Why?
|
GABA Antagonists | 1 | 2021 | 120 | 0.190 |
Why?
|
Mutation | 7 | 2021 | 29932 | 0.190 |
Why?
|
Referral and Consultation | 1 | 2014 | 3598 | 0.180 |
Why?
|
Enzyme Replacement Therapy | 1 | 2021 | 79 | 0.180 |
Why?
|
Human Rights Abuses | 1 | 2020 | 31 | 0.180 |
Why?
|
Language Disorders | 3 | 2007 | 138 | 0.180 |
Why?
|
Aicardi Syndrome | 1 | 2020 | 16 | 0.180 |
Why?
|
Governing Board | 1 | 2020 | 50 | 0.180 |
Why?
|
Central Nervous System Stimulants | 3 | 2003 | 1174 | 0.180 |
Why?
|
Organophosphorus Compounds | 1 | 2021 | 202 | 0.170 |
Why?
|
Rett Syndrome | 2 | 2019 | 164 | 0.170 |
Why?
|
Awards and Prizes | 1 | 2024 | 359 | 0.170 |
Why?
|
Education, Medical, Graduate | 1 | 2012 | 2363 | 0.170 |
Why?
|
Quality of Life | 1 | 2021 | 13308 | 0.170 |
Why?
|
Synaptic Transmission | 2 | 2024 | 1171 | 0.170 |
Why?
|
Deep Brain Stimulation | 1 | 2008 | 820 | 0.170 |
Why?
|
Arginine | 2 | 2020 | 934 | 0.170 |
Why?
|
RNA Splice Sites | 1 | 2020 | 211 | 0.170 |
Why?
|
Intracranial Hypertension | 1 | 2021 | 193 | 0.160 |
Why?
|
Neurosurgical Procedures | 2 | 2020 | 2056 | 0.160 |
Why?
|
Aspartic Acid | 1 | 2001 | 576 | 0.160 |
Why?
|
Positron-Emission Tomography | 3 | 2011 | 6465 | 0.160 |
Why?
|
Neurophysiology | 2 | 2016 | 144 | 0.160 |
Why?
|
Neonatal Screening | 2 | 2013 | 595 | 0.160 |
Why?
|
Facies | 2 | 2018 | 223 | 0.160 |
Why?
|
Epilepsy, Complex Partial | 2 | 2009 | 56 | 0.160 |
Why?
|
Frameshift Mutation | 1 | 2020 | 388 | 0.160 |
Why?
|
Germany | 1 | 2021 | 873 | 0.160 |
Why?
|
Physicians, Women | 1 | 2024 | 495 | 0.150 |
Why?
|
Critical Care | 3 | 2021 | 2699 | 0.150 |
Why?
|
Nerve Tissue Proteins | 1 | 2011 | 4407 | 0.150 |
Why?
|
Cognition | 4 | 2022 | 6957 | 0.150 |
Why?
|
Animals | 23 | 2024 | 167963 | 0.150 |
Why?
|
Headache | 1 | 2006 | 1249 | 0.150 |
Why?
|
Sleep | 4 | 2023 | 4751 | 0.150 |
Why?
|
Pregnant Women | 1 | 2023 | 563 | 0.150 |
Why?
|
Neurologic Examination | 1 | 2001 | 916 | 0.150 |
Why?
|
Comprehension | 2 | 2015 | 618 | 0.150 |
Why?
|
Students, Medical | 1 | 2011 | 1927 | 0.150 |
Why?
|
Cerebral Cortex | 5 | 2019 | 5761 | 0.150 |
Why?
|
Methyl-CpG-Binding Protein 2 | 1 | 2019 | 187 | 0.140 |
Why?
|
Heterozygote | 3 | 2020 | 2798 | 0.140 |
Why?
|
KCNQ2 Potassium Channel | 1 | 2017 | 19 | 0.140 |
Why?
|
Plasma | 1 | 2020 | 584 | 0.140 |
Why?
|
Mutagenesis, Site-Directed | 1 | 2020 | 1693 | 0.140 |
Why?
|
Abortion, Induced | 1 | 2023 | 460 | 0.140 |
Why?
|
GABA Modulators | 1 | 2017 | 109 | 0.140 |
Why?
|
Terminology as Topic | 1 | 2024 | 1535 | 0.140 |
Why?
|
Magnetic Resonance Spectroscopy | 3 | 2023 | 3765 | 0.140 |
Why?
|
Diagnosis, Differential | 7 | 2017 | 12965 | 0.140 |
Why?
|
Consensus | 2 | 2024 | 3113 | 0.140 |
Why?
|
GABA Plasma Membrane Transport Proteins | 1 | 2016 | 29 | 0.140 |
Why?
|
Energy Metabolism | 1 | 2008 | 2869 | 0.140 |
Why?
|
Diffusion Magnetic Resonance Imaging | 1 | 2008 | 2782 | 0.140 |
Why?
|
Early Diagnosis | 1 | 2021 | 1180 | 0.140 |
Why?
|
Language Tests | 5 | 2012 | 190 | 0.140 |
Why?
|
Verbal Behavior | 3 | 2007 | 335 | 0.140 |
Why?
|
Myoclonus | 1 | 2017 | 107 | 0.130 |
Why?
|
Standard of Care | 1 | 2020 | 552 | 0.130 |
Why?
|
Child Behavior | 1 | 2002 | 847 | 0.130 |
Why?
|
Electrophysiological Phenomena | 1 | 2018 | 309 | 0.130 |
Why?
|
Tomography, Emission-Computed, Single-Photon | 2 | 2021 | 1067 | 0.130 |
Why?
|
Malformations of Cortical Development | 1 | 2018 | 177 | 0.130 |
Why?
|
Focus Groups | 1 | 2021 | 1378 | 0.130 |
Why?
|
Clinical Protocols | 1 | 2021 | 1440 | 0.130 |
Why?
|
Epilepsy, Generalized | 1 | 2018 | 178 | 0.130 |
Why?
|
Homozygote | 1 | 2020 | 1788 | 0.130 |
Why?
|
Laser Therapy | 1 | 2022 | 1089 | 0.130 |
Why?
|
Obsessive-Compulsive Disorder | 2 | 2020 | 1489 | 0.130 |
Why?
|
Corpus Callosum | 1 | 2020 | 749 | 0.130 |
Why?
|
Channelopathies | 1 | 2015 | 30 | 0.130 |
Why?
|
Clinical Competence | 1 | 2011 | 4783 | 0.120 |
Why?
|
Vesicular Transport Proteins | 1 | 2018 | 374 | 0.120 |
Why?
|
Pitch Perception | 1 | 2015 | 101 | 0.120 |
Why?
|
Patient Care | 1 | 2020 | 624 | 0.120 |
Why?
|
Homeodomain Proteins | 1 | 2024 | 2414 | 0.120 |
Why?
|
Siblings | 1 | 2019 | 824 | 0.120 |
Why?
|
Seizures, Febrile | 1 | 2015 | 108 | 0.120 |
Why?
|
Genetic Predisposition to Disease | 2 | 2014 | 17790 | 0.120 |
Why?
|
United Arab Emirates | 1 | 2014 | 48 | 0.120 |
Why?
|
Longitudinal Studies | 3 | 2021 | 14495 | 0.110 |
Why?
|
MELAS Syndrome | 1 | 2014 | 56 | 0.110 |
Why?
|
Pharmaceutical Preparations | 1 | 2022 | 1091 | 0.110 |
Why?
|
Symbiosis | 1 | 2016 | 291 | 0.110 |
Why?
|
Myelin Sheath | 2 | 2008 | 652 | 0.110 |
Why?
|
Consciousness Disorders | 1 | 2017 | 440 | 0.100 |
Why?
|
Receptors, GABA-B | 1 | 2012 | 58 | 0.100 |
Why?
|
Irritable Mood | 1 | 2013 | 194 | 0.100 |
Why?
|
Internship and Residency | 1 | 2012 | 5870 | 0.100 |
Why?
|
Tomography, X-Ray Computed | 2 | 2015 | 20509 | 0.100 |
Why?
|
Epilepsy, Absence | 2 | 2017 | 49 | 0.100 |
Why?
|
Age Factors | 6 | 2018 | 18416 | 0.100 |
Why?
|
Neuroendocrinology | 1 | 2011 | 5 | 0.100 |
Why?
|
Mice | 12 | 2024 | 81208 | 0.100 |
Why?
|
Benzodiazepines | 1 | 2017 | 1131 | 0.100 |
Why?
|
Fluorodeoxyglucose F18 | 3 | 2023 | 2007 | 0.100 |
Why?
|
Video Recording | 1 | 2016 | 955 | 0.100 |
Why?
|
Technology Assessment, Biomedical | 1 | 2014 | 306 | 0.100 |
Why?
|
Genetic Counseling | 1 | 2015 | 624 | 0.090 |
Why?
|
Quality Control | 1 | 2014 | 828 | 0.090 |
Why?
|
Prospective Studies | 8 | 2023 | 54303 | 0.090 |
Why?
|
Prognosis | 10 | 2024 | 29658 | 0.090 |
Why?
|
HEK293 Cells | 1 | 2020 | 4264 | 0.090 |
Why?
|
Encephalitis | 2 | 2017 | 437 | 0.090 |
Why?
|
History, 20th Century | 3 | 2012 | 2773 | 0.090 |
Why?
|
Plants, Medicinal | 1 | 2011 | 166 | 0.090 |
Why?
|
Subthalamic Nucleus | 1 | 2013 | 193 | 0.090 |
Why?
|
Certification | 1 | 2014 | 421 | 0.090 |
Why?
|
Behavioral Medicine | 1 | 2011 | 50 | 0.090 |
Why?
|
Health Behavior | 1 | 2002 | 2622 | 0.090 |
Why?
|
Intensive Care Units, Neonatal | 1 | 2017 | 833 | 0.090 |
Why?
|
Intensive Care Units, Pediatric | 1 | 2017 | 1014 | 0.090 |
Why?
|
Disease Management | 2 | 2020 | 2514 | 0.090 |
Why?
|
Methylphenidate | 2 | 2005 | 488 | 0.090 |
Why?
|
Hodgkin Disease | 3 | 1993 | 1378 | 0.090 |
Why?
|
Follow-Up Studies | 8 | 2018 | 39261 | 0.080 |
Why?
|
Mitochondrial Diseases | 1 | 2013 | 340 | 0.080 |
Why?
|
Vision Disorders | 1 | 2017 | 1084 | 0.080 |
Why?
|
Vitamin B 6 Deficiency | 1 | 2009 | 18 | 0.080 |
Why?
|
Sequence Analysis, DNA | 2 | 2011 | 4713 | 0.080 |
Why?
|
Nerve Net | 3 | 2008 | 2261 | 0.080 |
Why?
|
Karyotyping | 1 | 2011 | 1171 | 0.080 |
Why?
|
Glutamic Acid | 3 | 2011 | 1167 | 0.080 |
Why?
|
Central Nervous System Diseases | 1 | 2013 | 521 | 0.080 |
Why?
|
DNA, Mitochondrial | 1 | 2014 | 858 | 0.080 |
Why?
|
Extracorporeal Membrane Oxygenation | 1 | 2020 | 1459 | 0.080 |
Why?
|
United States | 7 | 2023 | 72461 | 0.080 |
Why?
|
Autophagy | 1 | 2017 | 1337 | 0.080 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2021 | 3616 | 0.080 |
Why?
|
Alanine | 1 | 2011 | 606 | 0.080 |
Why?
|
Internationality | 1 | 2014 | 1004 | 0.080 |
Why?
|
Carbon Radioisotopes | 1 | 2009 | 557 | 0.080 |
Why?
|
Cross-Sectional Studies | 3 | 2021 | 25942 | 0.080 |
Why?
|
Scalp | 2 | 2022 | 389 | 0.080 |
Why?
|
Hippocampus | 1 | 2021 | 3738 | 0.080 |
Why?
|
Multifactorial Inheritance | 1 | 2016 | 1365 | 0.080 |
Why?
|
Death, Sudden | 1 | 2010 | 302 | 0.080 |
Why?
|
Muscle Rigidity | 1 | 1988 | 40 | 0.080 |
Why?
|
Spine | 1 | 2015 | 1111 | 0.070 |
Why?
|
Remission, Spontaneous | 1 | 2008 | 384 | 0.070 |
Why?
|
PTEN Phosphohydrolase | 1 | 2013 | 1115 | 0.070 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2017 | 2058 | 0.070 |
Why?
|
Measles | 1 | 1990 | 185 | 0.070 |
Why?
|
Dietary Supplements | 1 | 2020 | 3392 | 0.070 |
Why?
|
Infant, Premature | 1 | 2017 | 2092 | 0.070 |
Why?
|
Failure to Thrive | 1 | 2008 | 140 | 0.070 |
Why?
|
Communication | 2 | 2020 | 3849 | 0.070 |
Why?
|
Preoperative Care | 3 | 2018 | 2256 | 0.070 |
Why?
|
Comorbidity | 2 | 2021 | 10551 | 0.070 |
Why?
|
Psychophysiologic Disorders | 1 | 2009 | 221 | 0.070 |
Why?
|
Parkinson Disease | 1 | 2021 | 2859 | 0.070 |
Why?
|
Electrodes | 2 | 2022 | 614 | 0.070 |
Why?
|
Cohort Studies | 6 | 2021 | 41335 | 0.070 |
Why?
|
Computer Simulation | 1 | 2020 | 6218 | 0.070 |
Why?
|
History, 19th Century | 1 | 2009 | 720 | 0.070 |
Why?
|
Middle Aged | 20 | 2024 | 220352 | 0.070 |
Why?
|
Preoperative Period | 2 | 2020 | 555 | 0.070 |
Why?
|
Amino Acid Substitution | 1 | 2011 | 1737 | 0.070 |
Why?
|
Genetic Testing | 2 | 2020 | 3531 | 0.070 |
Why?
|
Behavioral Symptoms | 1 | 2008 | 185 | 0.070 |
Why?
|
Proteins | 1 | 2021 | 6029 | 0.070 |
Why?
|
Recreation | 1 | 2006 | 120 | 0.070 |
Why?
|
Neurosciences | 1 | 2011 | 353 | 0.070 |
Why?
|
Time Factors | 7 | 2017 | 40165 | 0.070 |
Why?
|
Arm | 1 | 2009 | 583 | 0.070 |
Why?
|
Predictive Value of Tests | 6 | 2021 | 15289 | 0.060 |
Why?
|
Equipment Failure | 1 | 2008 | 577 | 0.060 |
Why?
|
Globus Pallidus | 2 | 2003 | 249 | 0.060 |
Why?
|
Models, Biological | 4 | 2012 | 9467 | 0.060 |
Why?
|
Fluorescein Angiography | 1 | 2010 | 1045 | 0.060 |
Why?
|
Folic Acid Deficiency | 1 | 2005 | 117 | 0.060 |
Why?
|
Diet | 1 | 2023 | 8010 | 0.060 |
Why?
|
Awareness | 1 | 2009 | 646 | 0.060 |
Why?
|
Transcription Factors | 1 | 2024 | 12103 | 0.060 |
Why?
|
Mouth | 1 | 1987 | 380 | 0.060 |
Why?
|
Psychophysiology | 1 | 2004 | 136 | 0.060 |
Why?
|
Biogenic Monoamines | 1 | 2004 | 50 | 0.060 |
Why?
|
Adaptation, Psychological | 2 | 2006 | 2628 | 0.060 |
Why?
|
Temporal Lobe | 2 | 2009 | 1688 | 0.060 |
Why?
|
Reproducibility of Results | 6 | 2023 | 20080 | 0.060 |
Why?
|
Serotonin Plasma Membrane Transport Proteins | 1 | 2005 | 324 | 0.060 |
Why?
|
Diabetes Insipidus | 1 | 2004 | 144 | 0.060 |
Why?
|
Academies and Institutes | 1 | 2006 | 319 | 0.060 |
Why?
|
Severity of Illness Index | 2 | 2020 | 15840 | 0.060 |
Why?
|
Parent-Child Relations | 1 | 2008 | 758 | 0.050 |
Why?
|
Chromosomes, Human, Pair 22 | 1 | 2004 | 346 | 0.050 |
Why?
|
Glutamate Decarboxylase | 1 | 2004 | 239 | 0.050 |
Why?
|
Personhood | 1 | 2023 | 31 | 0.050 |
Why?
|
Dominance, Cerebral | 1 | 2004 | 622 | 0.050 |
Why?
|
Family Health | 1 | 2008 | 1257 | 0.050 |
Why?
|
Catheterization, Central Venous | 1 | 2008 | 526 | 0.050 |
Why?
|
Evoked Potentials | 1 | 2009 | 1036 | 0.050 |
Why?
|
Analysis of Variance | 4 | 2017 | 6238 | 0.050 |
Why?
|
Hospital Mortality | 1 | 2017 | 5425 | 0.050 |
Why?
|
Cytogenetics | 1 | 2003 | 198 | 0.050 |
Why?
|
Frontal Lobe | 1 | 2009 | 1420 | 0.050 |
Why?
|
Measles-Mumps-Rubella Vaccine | 1 | 2003 | 72 | 0.050 |
Why?
|
Neural Conduction | 1 | 2024 | 441 | 0.050 |
Why?
|
Mice, Knockout | 4 | 2011 | 14372 | 0.050 |
Why?
|
Brain Chemistry | 2 | 2003 | 959 | 0.050 |
Why?
|
Electromagnetic Phenomena | 1 | 2023 | 161 | 0.050 |
Why?
|
Syndrome | 2 | 2005 | 3280 | 0.050 |
Why?
|
Pregnancy Outcome | 1 | 1993 | 2907 | 0.050 |
Why?
|
Child Care | 1 | 2003 | 121 | 0.050 |
Why?
|
Limbic System | 1 | 2004 | 419 | 0.050 |
Why?
|
Mice, Transgenic | 3 | 2010 | 9530 | 0.050 |
Why?
|
Neuronavigation | 1 | 2022 | 164 | 0.050 |
Why?
|
Brain Neoplasms | 1 | 2022 | 8986 | 0.050 |
Why?
|
Tuberous Sclerosis | 2 | 2020 | 1030 | 0.050 |
Why?
|
Genes, Recessive | 1 | 2003 | 626 | 0.040 |
Why?
|
Genotype | 3 | 2023 | 12960 | 0.040 |
Why?
|
Putamen | 1 | 2021 | 291 | 0.040 |
Why?
|
Academic Medical Centers | 1 | 2011 | 2754 | 0.040 |
Why?
|
Attitude to Health | 2 | 2008 | 2029 | 0.040 |
Why?
|
Protein C Deficiency | 1 | 1999 | 25 | 0.040 |
Why?
|
Cerebrovascular Disorders | 1 | 1987 | 1501 | 0.040 |
Why?
|
Reaction Time | 2 | 2024 | 2075 | 0.040 |
Why?
|
Nervous System | 1 | 2003 | 543 | 0.040 |
Why?
|
Dopamine | 2 | 2023 | 1595 | 0.040 |
Why?
|
Herpes Zoster Ophthalmicus | 1 | 1999 | 37 | 0.040 |
Why?
|
Chromosome Deletion | 1 | 2004 | 1387 | 0.040 |
Why?
|
Evaluation Studies as Topic | 1 | 2021 | 1628 | 0.040 |
Why?
|
Prednisolone | 1 | 2020 | 327 | 0.040 |
Why?
|
Education, Medical | 1 | 2011 | 1727 | 0.040 |
Why?
|
Hyperthyroidism | 1 | 2001 | 291 | 0.040 |
Why?
|
Tomography, Emission-Computed | 1 | 2002 | 1121 | 0.040 |
Why?
|
Cross-Over Studies | 2 | 2021 | 2061 | 0.040 |
Why?
|
Base Sequence | 1 | 2010 | 12446 | 0.040 |
Why?
|
Spectrum Analysis | 1 | 2021 | 453 | 0.040 |
Why?
|
Reading | 1 | 2002 | 529 | 0.040 |
Why?
|
Sleep, REM | 1 | 2002 | 593 | 0.040 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2008 | 10827 | 0.040 |
Why?
|
Lasers | 1 | 2022 | 952 | 0.040 |
Why?
|
Substance Withdrawal Syndrome | 2 | 2002 | 622 | 0.040 |
Why?
|
Adrenocorticotropic Hormone | 1 | 2020 | 618 | 0.040 |
Why?
|
Neuroprotective Agents | 1 | 2005 | 961 | 0.040 |
Why?
|
Serotonin | 1 | 2003 | 1040 | 0.040 |
Why?
|
Videoconferencing | 1 | 2020 | 203 | 0.040 |
Why?
|
Ethics, Medical | 1 | 2023 | 783 | 0.040 |
Why?
|
Curriculum | 1 | 2011 | 3718 | 0.040 |
Why?
|
Myoclonic Epilepsy, Juvenile | 1 | 2017 | 13 | 0.040 |
Why?
|
Cerebrospinal Fluid | 1 | 2020 | 544 | 0.040 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2017 | 15789 | 0.040 |
Why?
|
Risk Factors | 4 | 2021 | 74359 | 0.040 |
Why?
|
Amino Acids | 1 | 2023 | 1714 | 0.040 |
Why?
|
Protein Binding | 1 | 2009 | 9335 | 0.040 |
Why?
|
Bipolar Disorder | 2 | 2006 | 5078 | 0.030 |
Why?
|
Hospital Units | 1 | 2018 | 142 | 0.030 |
Why?
|
Abnormalities, Multiple | 1 | 2004 | 1415 | 0.030 |
Why?
|
Nerve Degeneration | 1 | 2001 | 748 | 0.030 |
Why?
|
Monoamine Oxidase Inhibitors | 1 | 2017 | 155 | 0.030 |
Why?
|
Oscillometry | 1 | 2016 | 145 | 0.030 |
Why?
|
Hypothyroidism | 1 | 2001 | 665 | 0.030 |
Why?
|
Histidine | 1 | 2017 | 311 | 0.030 |
Why?
|
Models, Molecular | 2 | 2016 | 5434 | 0.030 |
Why?
|
Cholinergic Antagonists | 1 | 2017 | 164 | 0.030 |
Why?
|
Radiopharmaceuticals | 3 | 2016 | 2634 | 0.030 |
Why?
|
Lactic Acid | 1 | 2001 | 1134 | 0.030 |
Why?
|
Hashimoto Disease | 1 | 2017 | 105 | 0.030 |
Why?
|
Image Processing, Computer-Assisted | 2 | 2012 | 8950 | 0.030 |
Why?
|
Prenatal Diagnosis | 1 | 2023 | 1264 | 0.030 |
Why?
|
Dogs | 1 | 2020 | 3841 | 0.030 |
Why?
|
Fetus | 1 | 2023 | 1859 | 0.030 |
Why?
|
Transforming Growth Factor beta | 1 | 2023 | 1959 | 0.030 |
Why?
|
Neuronal Plasticity | 3 | 2009 | 1430 | 0.030 |
Why?
|
Physicians | 1 | 2013 | 4591 | 0.030 |
Why?
|
Chromatography, High Pressure Liquid | 2 | 2012 | 1544 | 0.030 |
Why?
|
Neuropsychological Tests | 3 | 2017 | 7021 | 0.030 |
Why?
|
Prolactin | 1 | 2017 | 621 | 0.030 |
Why?
|
Monitoring, Ambulatory | 1 | 2018 | 353 | 0.030 |
Why?
|
Logistic Models | 2 | 2021 | 13314 | 0.030 |
Why?
|
Evoked Potentials, Visual | 1 | 2017 | 415 | 0.030 |
Why?
|
Dopamine Agonists | 1 | 2017 | 352 | 0.030 |
Why?
|
Single-Blind Method | 1 | 2018 | 1578 | 0.030 |
Why?
|
International Cooperation | 1 | 2020 | 1433 | 0.030 |
Why?
|
Image Interpretation, Computer-Assisted | 1 | 2007 | 3340 | 0.030 |
Why?
|
Cluster Analysis | 1 | 2021 | 2698 | 0.030 |
Why?
|
Health Resources | 1 | 2020 | 935 | 0.030 |
Why?
|
Length of Stay | 2 | 2018 | 6479 | 0.030 |
Why?
|
Respiration Disorders | 1 | 2017 | 368 | 0.030 |
Why?
|
Risk | 1 | 2005 | 9631 | 0.030 |
Why?
|
Dementia | 1 | 1988 | 2649 | 0.030 |
Why?
|
Equipment and Supplies | 1 | 2016 | 275 | 0.030 |
Why?
|
Intensive Care Units | 2 | 2017 | 3736 | 0.030 |
Why?
|
GABA-B Receptor Antagonists | 1 | 2012 | 11 | 0.030 |
Why?
|
Hamartoma Syndrome, Multiple | 1 | 2013 | 114 | 0.030 |
Why?
|
Prevalence | 2 | 2023 | 15687 | 0.030 |
Why?
|
Stress, Psychological | 1 | 2008 | 4446 | 0.030 |
Why?
|
Infant, Low Birth Weight | 1 | 2017 | 859 | 0.030 |
Why?
|
Body Temperature | 1 | 2016 | 777 | 0.030 |
Why?
|
Parents | 2 | 2003 | 3549 | 0.030 |
Why?
|
Atrophy | 2 | 2010 | 1627 | 0.020 |
Why?
|
Cephalometry | 1 | 2013 | 382 | 0.020 |
Why?
|
Phenytoin | 1 | 2012 | 188 | 0.020 |
Why?
|
Cysteine | 1 | 2017 | 895 | 0.020 |
Why?
|
Attention | 1 | 2002 | 2387 | 0.020 |
Why?
|
Physical Examination | 1 | 2017 | 1244 | 0.020 |
Why?
|
Signal Processing, Computer-Assisted | 1 | 2018 | 1489 | 0.020 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2016 | 1347 | 0.020 |
Why?
|
District of Columbia | 1 | 2011 | 160 | 0.020 |
Why?
|
Health Promotion | 1 | 2003 | 2206 | 0.020 |
Why?
|
Vaccination | 1 | 2003 | 3361 | 0.020 |
Why?
|
Hypothermia, Induced | 1 | 2016 | 758 | 0.020 |
Why?
|
Circadian Rhythm | 1 | 2002 | 2571 | 0.020 |
Why?
|
Glasgow Coma Scale | 1 | 2012 | 579 | 0.020 |
Why?
|
Guidelines as Topic | 1 | 2017 | 1392 | 0.020 |
Why?
|
Aldehydes | 1 | 2011 | 170 | 0.020 |
Why?
|
Primary Health Care | 2 | 2005 | 4647 | 0.020 |
Why?
|
Cell Line | 1 | 2024 | 15620 | 0.020 |
Why?
|
Gene Expression Profiling | 1 | 2006 | 9411 | 0.020 |
Why?
|
North America | 1 | 2013 | 1284 | 0.020 |
Why?
|
Photic Stimulation | 1 | 2016 | 1967 | 0.020 |
Why?
|
Epilepsy, Temporal Lobe | 1 | 2013 | 387 | 0.020 |
Why?
|
Point Mutation | 1 | 2014 | 1594 | 0.020 |
Why?
|
Amino Acid Sequence | 1 | 2020 | 13451 | 0.020 |
Why?
|
Catalytic Domain | 1 | 2011 | 706 | 0.020 |
Why?
|
Patient Compliance | 2 | 2012 | 2688 | 0.020 |
Why?
|
Depression | 1 | 2008 | 8044 | 0.020 |
Why?
|
Electrocardiography | 1 | 2021 | 6414 | 0.020 |
Why?
|
Pilot Projects | 1 | 2021 | 8555 | 0.020 |
Why?
|
Area Under Curve | 1 | 2012 | 1636 | 0.020 |
Why?
|
Laparotomy | 1 | 1990 | 465 | 0.020 |
Why?
|
Stroke | 2 | 2001 | 9962 | 0.020 |
Why?
|
Saliva | 1 | 2012 | 820 | 0.020 |
Why?
|
Radiography | 2 | 2010 | 6965 | 0.020 |
Why?
|
Sensitivity and Specificity | 2 | 2016 | 14660 | 0.020 |
Why?
|
Double-Blind Method | 1 | 2021 | 12427 | 0.020 |
Why?
|
Pregnancy | 2 | 2023 | 29749 | 0.020 |
Why?
|
Creatinine | 1 | 2012 | 1903 | 0.020 |
Why?
|
Carotid Artery Injuries | 1 | 1987 | 96 | 0.020 |
Why?
|
Intestinal Obstruction | 1 | 1990 | 434 | 0.020 |
Why?
|
Intelligence Tests | 1 | 2007 | 500 | 0.020 |
Why?
|
Retina | 1 | 2017 | 2635 | 0.020 |
Why?
|
Tandem Mass Spectrometry | 1 | 2012 | 1189 | 0.020 |
Why?
|
History, 21st Century | 1 | 2012 | 1575 | 0.020 |
Why?
|
Anemia, Hemolytic | 1 | 1987 | 163 | 0.020 |
Why?
|
Mass Spectrometry | 1 | 2013 | 2192 | 0.020 |
Why?
|
Random Allocation | 1 | 2010 | 2394 | 0.020 |
Why?
|
Principal Component Analysis | 1 | 2008 | 940 | 0.020 |
Why?
|
Parasomnias | 1 | 2005 | 27 | 0.020 |
Why?
|
Hypoventilation | 1 | 2005 | 44 | 0.020 |
Why?
|
Protein Kinases | 1 | 2012 | 1612 | 0.020 |
Why?
|
Glomerulonephritis | 1 | 1987 | 337 | 0.020 |
Why?
|
Odds Ratio | 1 | 2017 | 9716 | 0.020 |
Why?
|
Oxidation-Reduction | 1 | 2011 | 2222 | 0.020 |
Why?
|
Ethiodized Oil | 1 | 1984 | 25 | 0.010 |
Why?
|
Neurons | 1 | 2023 | 9426 | 0.010 |
Why?
|
Tamoxifen | 1 | 1989 | 963 | 0.010 |
Why?
|
Homovanillic Acid | 1 | 2003 | 75 | 0.010 |
Why?
|
Hydroxyindoleacetic Acid | 1 | 2003 | 93 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2017 | 12159 | 0.010 |
Why?
|
Semantics | 1 | 2007 | 599 | 0.010 |
Why?
|
Chromatography, Ion Exchange | 1 | 2003 | 297 | 0.010 |
Why?
|
Sex Factors | 1 | 2017 | 10547 | 0.010 |
Why?
|
Tics | 1 | 2003 | 73 | 0.010 |
Why?
|
Psychiatric Status Rating Scales | 1 | 2013 | 6015 | 0.010 |
Why?
|
Narcolepsy | 1 | 2005 | 199 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2021 | 22023 | 0.010 |
Why?
|
Carotid Arteries | 1 | 1987 | 951 | 0.010 |
Why?
|
Streptococcal Infections | 1 | 1987 | 617 | 0.010 |
Why?
|
Spleen | 1 | 1988 | 2298 | 0.010 |
Why?
|
Delivery of Health Care | 1 | 2020 | 5325 | 0.010 |
Why?
|
Feasibility Studies | 1 | 2012 | 5201 | 0.010 |
Why?
|
Carcinoma, Intraductal, Noninfiltrating | 1 | 1989 | 936 | 0.010 |
Why?
|
Gene Expression Regulation, Enzymologic | 1 | 2006 | 1173 | 0.010 |
Why?
|
Genome-Wide Association Study | 1 | 2020 | 12626 | 0.010 |
Why?
|
Hallucinations | 1 | 2003 | 366 | 0.010 |
Why?
|
Child Development Disorders, Pervasive | 1 | 2005 | 599 | 0.010 |
Why?
|
Registries | 1 | 2017 | 8469 | 0.010 |
Why?
|
Social Behavior | 1 | 2006 | 1131 | 0.010 |
Why?
|
Delayed-Action Preparations | 1 | 2003 | 961 | 0.010 |
Why?
|
Speech Perception | 1 | 2004 | 505 | 0.010 |
Why?
|
Survival Analysis | 1 | 2012 | 10182 | 0.010 |
Why?
|
Drug Resistance | 1 | 2005 | 1617 | 0.010 |
Why?
|
Glycine | 1 | 2003 | 662 | 0.010 |
Why?
|
Cooperative Behavior | 1 | 2006 | 1500 | 0.010 |
Why?
|
Disease Progression | 1 | 2016 | 13502 | 0.010 |
Why?
|
Thrombocytopenia | 1 | 1987 | 1174 | 0.010 |
Why?
|
Adaptation, Physiological | 1 | 2005 | 1296 | 0.010 |
Why?
|
Reference Values | 1 | 2005 | 4925 | 0.010 |
Why?
|
In Situ Hybridization, Fluorescence | 1 | 2004 | 2506 | 0.010 |
Why?
|
Hospitalization | 1 | 2018 | 10790 | 0.010 |
Why?
|
Pedigree | 1 | 2005 | 4578 | 0.010 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2006 | 3775 | 0.010 |
Why?
|
Aged, 80 and over | 2 | 2012 | 58995 | 0.010 |
Why?
|
Statistics as Topic | 1 | 2003 | 2362 | 0.010 |
Why?
|
Anorexia Nervosa | 1 | 2005 | 1361 | 0.010 |
Why?
|
Clinical Trials as Topic | 1 | 2012 | 8056 | 0.010 |
Why?
|
Drug Therapy, Combination | 1 | 2006 | 6498 | 0.010 |
Why?
|
Teaching | 1 | 2003 | 1169 | 0.010 |
Why?
|
Polymorphism, Genetic | 1 | 2005 | 4291 | 0.010 |
Why?
|
Liver | 2 | 1988 | 7509 | 0.010 |
Why?
|
Alcoholism | 1 | 2005 | 1961 | 0.010 |
Why?
|
Polymerase Chain Reaction | 1 | 2004 | 6068 | 0.010 |
Why?
|
Neural Pathways | 1 | 2005 | 3040 | 0.010 |
Why?
|
Acute Kidney Injury | 1 | 1987 | 1941 | 0.010 |
Why?
|
Cerebrovascular Circulation | 1 | 2004 | 2733 | 0.010 |
Why?
|
Sleep Initiation and Maintenance Disorders | 1 | 2003 | 1079 | 0.010 |
Why?
|
Psychomotor Performance | 1 | 2002 | 1878 | 0.010 |
Why?
|
Risk Assessment | 1 | 2015 | 24123 | 0.010 |
Why?
|
Signal Transduction | 1 | 2017 | 23376 | 0.010 |
Why?
|
Carcinoma, Hepatocellular | 1 | 1984 | 2299 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2008 | 22053 | 0.010 |
Why?
|
Aged | 3 | 2012 | 169152 | 0.010 |
Why?
|
Liver Neoplasms | 1 | 1984 | 4319 | 0.000 |
Why?
|
Granuloma | 1 | 1988 | 327 | 0.000 |
Why?
|
Kidney Glomerulus | 1 | 1987 | 568 | 0.000 |
Why?
|
Lung Neoplasms | 1 | 1989 | 13262 | 0.000 |
Why?
|
Intestine, Small | 1 | 1990 | 1207 | 0.000 |
Why?
|
Radiotherapy | 1 | 1990 | 1504 | 0.000 |
Why?
|
Remission Induction | 1 | 1989 | 2392 | 0.000 |
Why?
|
Breast Neoplasms | 1 | 1989 | 21025 | 0.000 |
Why?
|
Lymphatic Metastasis | 1 | 1989 | 2943 | 0.000 |
Why?
|
Menopause | 1 | 1989 | 1640 | 0.000 |
Why?
|
Combined Modality Therapy | 1 | 1990 | 8552 | 0.000 |
Why?
|
Acute Disease | 1 | 1987 | 7269 | 0.000 |
Why?
|
Recurrence | 1 | 1988 | 8482 | 0.000 |
Why?
|
Neoplasm Staging | 1 | 1990 | 11152 | 0.000 |
Why?
|